ALXO
ALX Oncology Holdings Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$2.01
+$0.14
(+7.49%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $263.71M | EPS (ttm) | $-2.01 | Current Price | $2.01 |
| Enterprise Value | $63.96M | Forward EPS | $-0.75 | Previous Close | $1.87 |
| P/E Ratio | - | ROA | -50.50% | 52W High | $2.27 |
| Forward P/E | -2.68 | ROE | -118.95% | 52W Low | $0.40 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $1.39 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $1.04 |
| P/B Ratio | 2.40 | Profit Margin | - | Volume | 1.32M |
| EV/EBITDA | -0.59 | Current Ratio | 2.40 | Avg Volume | 308.17K |
| EV/Sales | - | Quick Ratio | 2.20 | Beta | 0.52 |
| Employees | 44.00 | Debt/Equity | 34.84 | Shares Outstanding | 131.20M |
| Sector | Healthcare | Total Debt | $15.61M | Float Shares | 29.05M |
| Industry | Biotechnology | Total Cash | $60.63M | Short Float | 3.16% |
| Optionable | - | Cash/Share | $1.12 | Short Ratio | 5.20 |
| Dividend Yield | - | Book Value/Share | $0.84 | % Held by Insiders | 2.71% |
| Target Price | $3.00 | Revenue (TTM) | - | % Held by Institutions | 66.66% |